Tag: business update

August 17, 2018

Cannabis Weekly Round-Up: Ontario Cannabis Shops Arriving in 2019

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
August 3, 2018

Cannabis Weekly Round-Up: HEXO Gets Partnership with Alcohol Producer

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
July 13, 2018

Weekly Round-Up: New Deal Splits Hiku-WeedMD Merger

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 29, 2018

Cannabis Weekly Round-Up: Manitoba Awards New Supply Agreements

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 15, 2018

Cannabis Weekly Round-Up: The Amendment Fight for Bill C-45

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 1, 2018

Cannabis Weekly Round-Up: Lift Cannabis Expo Takes Charge

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 9, 2018

argenx reports first quarter 2018 financial results and provides business update

argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment...
May 9, 2018

Alder BioPharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Alder BioPharmaceuticals (NASDAQ:ALDR) a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today provided a...
May 9, 2018

VIVUS Reports First Quarter 2018 Financial Results

VIVUS (NASDAQ:VVUS) a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients...
May 8, 2018

Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients...